ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft PlugGlobeNewsWire • 04/13/23
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®GlobeNewsWire • 04/03/23
ZimVie's Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial ImplantsGlobeNewsWire • 03/23/23
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body TetheringGlobeNewsWire • 03/15/23
ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software ModulesGlobeNewsWire • 02/23/23
ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023GlobeNewsWire • 02/13/23
ZimVie Expands Navigation-Compatible Platform to Include Posterior Cervical ApplicationGlobeNewsWire • 10/11/22
ZimVie to Participate in the Morgan Stanley 20th Annual Global Healthcare ConferenceGlobeNewsWire • 08/29/22
ZimVie Inc. (ZIMV) CEO Vafa Jamali on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22